| Dr Charles Edward Clark, MD | |
|
74 Munsill Ave, Suite 100, Bristol, VT 05443-1032 | |
| (802) 453-5028 | |
| (802) 453-6105 |
| Full Name | Dr Charles Edward Clark |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 74 Munsill Ave, Bristol, Vermont |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609912427 | NPI | - | NPPES |
| VT5630 | Medicaid | VT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 0420006979 (Vermont) | Primary |
| Entity Name | Five-town Health Alliance, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871840843 PECOS PAC ID: 9638321342 Enrollment ID: O20121204000030 |
News Archive
Scientists have been exploring new ways to "smell" signs of cancer by analyzing what's in patients' breath. In ACS' journal Nano Letters, one team now reports new progress toward this goal. The researchers have developed a small array of flexible sensors, which accurately detect compounds in breath samples that are specific to ovarian cancer.
Medical Marijuana, Inc. announces today the purchase of 20 acres of prime mountain valley property in Southern California intended to be used within strict governmental guidelines as a research facility targeting medical Cannabis strains specific to a wide range of medical conditions.
Israeli researchers have successfully established a new approach for pacing the heart and synchronizing its mechanical activity without the use of a conventional electrical pacemaker. This novel biologic strategy employs light-sensitive genes that can be injected into the heart and then activated by flashes of blue light.
Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, announced that investigators at The University of Texas MD Anderson Cancer Center Department of Breast Medical Oncology have initiated a phase 1/2 study combining Syndax's lead product entinostat with lapatinib ditosylate (Tykerb) in patients with locally recurrent or distant relapsed metastatic breast cancer previously treated with trastuzumab (Herceptin).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Charles Edward Clark, MD 74 Munsill Ave, Suite 100, Bristol, VT 05443-1032 Ph: (802) 453-5028 | Dr Charles Edward Clark, MD 74 Munsill Ave, Suite 100, Bristol, VT 05443-1032 Ph: (802) 453-5028 |
News Archive
Scientists have been exploring new ways to "smell" signs of cancer by analyzing what's in patients' breath. In ACS' journal Nano Letters, one team now reports new progress toward this goal. The researchers have developed a small array of flexible sensors, which accurately detect compounds in breath samples that are specific to ovarian cancer.
Medical Marijuana, Inc. announces today the purchase of 20 acres of prime mountain valley property in Southern California intended to be used within strict governmental guidelines as a research facility targeting medical Cannabis strains specific to a wide range of medical conditions.
Israeli researchers have successfully established a new approach for pacing the heart and synchronizing its mechanical activity without the use of a conventional electrical pacemaker. This novel biologic strategy employs light-sensitive genes that can be injected into the heart and then activated by flashes of blue light.
Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, announced that investigators at The University of Texas MD Anderson Cancer Center Department of Breast Medical Oncology have initiated a phase 1/2 study combining Syndax's lead product entinostat with lapatinib ditosylate (Tykerb) in patients with locally recurrent or distant relapsed metastatic breast cancer previously treated with trastuzumab (Herceptin).
› Verified 5 days ago
Jeffrey S Wulfman, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 74 Munsill Ave, Suite 100, Bristol, VT 05443 Phone: 802-453-5028 Fax: 802-453-6105 | |
Natasha Alexa Withers, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 61 Pine St Ste 400, Bristol, VT 05443 Phone: 802-453-7422 Fax: 802-453-4815 | |
Jennifer R Wisdom-behounek, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 61 Pine St Bldg 4, Bristol, VT 05443 Phone: 573-884-7733 | |
Brian D. Bates, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 61 Pine St, Bristol, VT 05443 Phone: 802-453-5028 Fax: 802-453-6105 | |
William Harrison Porter, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 61 Pine St Bldg 4, Bristol, VT 05443 Phone: 802-453-5028 | |
Renee Bratspis, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 74 Munsill Ave Ste 100, Bristol, VT 05443 Phone: 802-453-5028 |